BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 19 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,262 | -42.0% | 95,656 | 0.0% | 0.00% | – |
| Q2 2023 | $66,002 | -91.3% | 95,656 | 0.0% | 0.00% | – |
| Q1 2023 | $754,725 | +1323978.9% | 95,656 | +49.0% | 0.00% | – |
| Q4 2022 | $57 | -99.9% | 64,196 | -0.2% | 0.00% | – |
| Q3 2022 | $70,000 | -11.4% | 64,355 | 0.0% | 0.00% | – |
| Q2 2022 | $79,000 | -42.3% | 64,355 | +10.3% | 0.00% | – |
| Q1 2022 | $137,000 | -23.9% | 58,341 | -0.0% | 0.00% | – |
| Q4 2021 | $180,000 | -24.1% | 58,350 | -0.0% | 0.00% | – |
| Q3 2021 | $237,000 | -16.0% | 58,375 | -0.0% | 0.00% | – |
| Q2 2021 | $282,000 | -14.3% | 58,380 | -8.0% | 0.00% | – |
| Q1 2021 | $329,000 | -21.7% | 63,448 | +0.7% | 0.00% | – |
| Q4 2020 | $420,000 | -32.8% | 63,017 | +2.6% | 0.00% | – |
| Q3 2020 | $625,000 | +15.3% | 61,443 | +42.1% | 0.00% | – |
| Q2 2020 | $542,000 | +271.2% | 43,253 | +223.4% | 0.00% | – |
| Q1 2020 | $146,000 | – | 13,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 90,884 | $606,000 | 1.02% |
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 1,009,231 | $6,732,000 | 0.78% |
| GSA CAPITAL PARTNERS LLP | 59,589 | $397,000 | 0.06% |
| DAVENPORT & Co LLC | 89,225 | $595,000 | 0.01% |
| Professional Financial Advisors, LLC | 788 | $5,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 13,185 | $88,000 | 0.00% |
| Renaissance Technologies | 214,299 | $1,429,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11,600 | $77,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 19,695 | $131,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,000 | $7,000 | 0.00% |